ABO rs12150767: Blood Lipids and Cardiovascular Markers
The rs12150767 single nucleotide polymorphism is a common genetic variant situated in the chromosome 9q34 region adjacent to the ABO gene. Large-scale genome-wide association studies (GWAS) have linked this locus with circulating lipid profiles and biomarkers of cardiovascular disease. However, the evidence directly assigning individual risk to this specific variant remains limited, reflecting complex biological interactions across the broader ABO region.
What each genotype means
Typical lipid-associated profile
This genotype is located within the ABO gene region, which has been identified in large-scale studies as being associated with variations in circulating lipid levels. Because this association is based on statistical trends across populations rather than a direct causal mechanism, it is not a diagnostic indicator of health. You should view this as a common genetic variation that contributes to the natural diversity of lipid profiles in the human population.
This genotype is common globally, though its specific frequency varies significantly depending on ancestral background.
Typical lipid-associated profile
This genotype is located within the ABO gene region, which has been identified in large-scale studies as being associated with variations in circulating lipid levels. Because this association is based on statistical trends across populations rather than a direct causal mechanism, it is not a diagnostic indicator of health. You should view this as a common genetic variation that contributes to the natural diversity of lipid profiles in the human population.
This genotype is common globally, though its specific frequency varies significantly depending on ancestral background.
Typical lipid-associated profile
This genotype is located within the ABO gene region, which has been identified in large-scale studies as being associated with variations in circulating lipid levels. Because this association is based on statistical trends across populations rather than a direct causal mechanism, it is not a diagnostic indicator of health. You should view this as a common genetic variation that contributes to the natural diversity of lipid profiles in the human population.
This genotype is common globally, though its specific frequency varies significantly depending on ancestral background.
What Is rs12150767 and Where Is It Located?
The single nucleotide polymorphism (SNP) rs12150767 is a genomic variant situated on the long arm of chromosome 9 (9q34.2) near the ABO gene locus. Like many variants uncovered in large-scale genetic research, it represents a single DNA base substitution found naturally across human populations. Because it resides in a non-coding genomic region, it does not directly alter the amino acid sequence of a protein. Instead, variants in this chromosomal neighborhood often act as regulatory elements that influence gene expression, or they serve as statistical markers in linkage disequilibrium—meaning they are inherited alongside other functional variants nearby. Because rs12150767 is part of a complex haplotype architecture spanning the ABO locus, researchers frequently study it to understand how regulatory variation in this chromosomal neighborhood correlates with broad metabolic and physiological traits.
The Biological Role of the ABO Locus
The ABO gene encodes glycosyltransferases—specialized enzymes that transfer specific sugar molecules onto cell-surface glycoproteins and glycolipids. While best known for establishing human A, B, AB, and O blood groups on red blood cells, ABO glycosyltransferases are expressed widely across vascular endothelial tissues and circulating plasma proteins. The enzymatic activity dictated by this locus alters the post-translational modification and clearance rates of several key circulating factors, including von Willebrand factor, cell adhesion molecules such as soluble E-selectin and ICAM-1, and various apolipoproteins. These carbohydrate modifications influence inflammatory responses, endothelial cell interactions, and blood clotting cascades. Consequently, the genomic region encompassing ABO has emerged as a major pleiotropic hub in human genetics, affecting not only hematologic phenotypes but also systemic cardiovascular biology.
Research Associations and Evidence Strength
Genome-wide association studies (GWAS) have repeatedly highlighted the ABO locus for its associations with circulating plasma lipid levels, including low-density lipoprotein cholesterol (LDL-C) and total cholesterol, as well as downstream markers of coronary artery disease and venous thromboembolism. Meta-analyses of lipidomics and cardiovascular traits regularly identify signals in the 9q34 region, where rs12150767 resides. However, the current scientific evidence directly linking rs12150767 to isolated clinical disease risk is classified as limited. Most observed statistical associations reflect modest effect sizes that explain only a tiny fraction of overall variation in lipid levels. Furthermore, because many variants in this region track closely with primary ABO blood group alleles, isolating the independent biological contribution of rs12150767 remains an active challenge for researchers.
Interpreting Your Genetic Results
Understanding a genetic result for rs12150767 requires recognizing the difference between statistical population associations and personal clinical diagnosis. Carrying a genotype correlated with slightly higher or lower lipid levels in research studies does not mean an individual is destined to develop dyslipidemia, atherosclerosis, or heart disease. Complex traits like cholesterol concentrations and cardiovascular health are shaped by dozens of common genetic variants working in concert, alongside powerful non-genetic factors including diet, physical activity, body composition, smoking status, and medication usage. Genetic variants with limited evidence, such as rs12150767, are not intended to guide medical decisions or replace standard clinical diagnostics like fasting lipid panels. Readers should always review lipid profiles and cardiovascular prevention strategies directly with a qualified healthcare provider.
How common is this variant?
The rs12150767 variant is recognized as a common polymorphism observed across diverse global populations, though allele frequencies can vary between major continental ancestries.
Frequently asked questions
Does having a specific rs12150767 genotype determine my ABO blood type?
No, rs12150767 does not directly establish your clinical ABO blood group. While it is located near the ABO gene and may be co-inherited with specific ABO alleles, traditional serological testing or targeted blood-group genotyping is necessary to accurately determine your blood type.
Can rs12150767 predict my risk of heart disease or stroke?
No, this single variant cannot predict individual cardiovascular disease risk. Population studies associate this locus with subtle variations in lipid biomarkers, but its effect size is very small, and clinical risk is governed by broader genetic, lifestyle, and medical factors.
Should I modify my medications based on this genetic result?
No, you should never start, stop, or change the dosage of any cardiovascular or lipid-lowering medication based on rs12150767 results. For any questions regarding prescription therapies or lipid management, consult your prescribing physician or a clinical pharmacist.
How are lipid levels typically evaluated if genetics only tell part of the story?
Physicians rely on standardized laboratory blood tests, such as fasting lipid panels that measure total cholesterol, LDL-C, HDL-C, and triglycerides. These direct physiological measurements, combined with overall cardiovascular risk assessments, provide actionable clinical information that genetics cannot replace.
Sources & further reading
Educational information only, last refreshed 9/7/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs12150767?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in ABO
Variant in the ABO blood group locus associated with plasma alkaline phosphatase levels and blood group determination.
A missense variant (Leu266Met) in the ABO gene that, in combination with other SNPs, determines ABO blood group status and is associated with cardiovascular and metabolic traits.
A common variant in the ABO blood group locus robustly associated with circulating levels of soluble adhesion molecules (sICAM-1) and venous thromboembolism risk.
This single nucleotide polymorphism in the ABO locus is strongly associated with circulating E-selectin, soluble ICAM-1 levels, and thrombosis risk.
Tagging variant in ABO associated with blood group phenotypes and longevity.
Regulatory variant at the ABO locus influencing plasma von Willebrand factor levels and venous thromboembolism risk.